Nucleic Acid Therapeutics Market is Boosted by Breakthroughs in RNA-Based Drug Development By 2025-2033 | Gilead Sciences, Inc., AstraZeneca, GSK plc, Novartis AG, BioNTech SE

The Global Nucleic Acid Therapeutics Market reached US$ 5.64 billion in 2024 and is expected to reach US$ 14.42 billion by 2032, growing at a CAGR of 10.9% during the forecast period 2025-2032.

The latest Nucleic Acid Therapeutics Market Report by DataM Intelligence offers a clear analysis of global trends, market size, key players, and growth drivers. Covering emerging technologies, evolving care models, and regulatory insights, it provides strategic intelligence to help stakeholders navigate the dynamic healthcare landscape through 2025-2033

Download exclusive insights with our detailed sample report (Corporate Email ID gets priority access):
https://www.datamintelligence.com/download-sample/nucleic-acid-therapeutics-market?ophp

These therapies use RNA or DNA to modify how genes behave, offering new ways to treat diseases at the molecular level. Strong research funding and breakthroughs in delivery technology are driving growth in North America and Europe, with Asia-Pacific investing heavily in R&D.

Nucleic Acid Therapeutics Market Competitors Overview:

Ionis Pharmaceuticals, Alnylam Pharmaceuticals, Inc., Gilead Sciences, Inc., AstraZeneca, Sarepta Therapeutics, Inc., Creative Biolabs, GSK plc, Novartis AG, BioNTech SE., and Silence Therapeutics among others.

Important Industry Updates of 2024 and 2025:

✅ In October 2024, Leal Therapeutics, Inc. announced a $45 million financing. The round was led by Newpath Partners, with additional new investors Chugai Venture Fund and Alexandria Venture Investments, in addition to existing investors OrbiMed, Euclidean Capital and PhiFund. This latest financing round follows a previously disclosed $39 million financing.

Nucleic Acid Therapeutics Market Segments Overview:

∎By category [Antisense Oligonucleotides (ASOs), Small Interfering RNA (siRNA), Messenger RNA (mRNA), Self-Amplifying RNA (saRNA)]
∎By application [Cancers, Viral Infections, Genetic Disorders, Others]
∎By end-user [Hospitals, Academic & Research Institutes]

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/nucleic-acid-therapeutics-market?ophp

Methodology and Scope:

This Nucleic Acid Therapeutics Market report is developed using a robust research methodology that combines primary interviews, insights from industry experts, and verified secondary sources such as company filings, trade journals, and trusted databases. It follows a bottom-up and top-down approach to ensure data accuracy through triangulation. The scope of the report covers current market trends, growth potential, and strategic developments across global and regional markets.

Regional Overview for Nucleic Acid Therapeutics Market:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Looking For Exclusive Full Report? Get it here: https://www.datamintelligence.com/buy-now-page?report=nucleic-acid-therapeutics-market?ophp

The Report Includes:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Go-to-market Strategy.
➡ Neutral perspective on the market performance.
➡ Customized regional/country reports as per request and country level analysis.
➡ Potential & niche segments and regions exhibiting promising growth covered.

People Also Ask:

➤ What are the global sales, production, import, and export trends in the Nucleic Acid Therapeutics market?
➤ Who are the top manufacturers, and what are their output, pricing, and revenue figures?
➤ What key opportunities and challenges do vendors face in this market?
➤ Which product types, applications, or end-users are driving growth and holding market share?
➤ What are the main growth drivers and restraints affecting the Nucleic Acid Therapeutics market?

Unlock 360° Market Intelligence with DataM Subscription Services:
https://www.datamintelligence.com/reports-subscription

✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drugs Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.